Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO

Objective ThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained. The purpose of this study was to determine values for minimal important change (MIC) for ThyPRO. Methods A total of 435 patients treated for be...

Full description

Saved in:
Bibliographic Details
Published inEndocrine Connections Vol. 10; no. 3; pp. 316 - 324
Main Authors Nordqvist, Selma Flora, Boesen, Victor Brun, Rasmussen, Åse Krogh, Feldt-Rasmussen, Ulla, Hegedüs, Laszlo, Bonnema, Steen Joop, Cramon, Per Karkov, Watt, Torquil, Groenvold, Mogens, Bjorner, Jakob Bue
Format Journal Article
LanguageEnglish
Published England Bioscientifica Ltd 01.03.2021
Bioscientifica
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective ThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained. The purpose of this study was to determine values for minimal important change (MIC) for ThyPRO. Methods A total of 435 patients treated for benign thyroid diseases completed ThyPRO at baseline and 6 weeks following treatment initiation. At 6 weeks follow-up, patients also completed Global Rating of Change items. For each 0–100 scale, two MIC values were identified: An MIC for groups, using the receiver operating characteristic (ROC) curve method and an MIC for individual patients, using the Reliable Change Index. Results ROC analyses provided group-MIC estimates of 6.3–14.3 (score range 0–100). Evaluation of area under the curve (AUC) supported the robustness for 9 of 14 scales (AUC > 0.7). Reliable Change Index estimates of individual-MIC were 8.0–21.1. For all scales but two, the individual-MIC values were larger than the group-MIC values. Conclusions Interpretability of ThyPRO was improved by the establishment of MIC values, which was 6.3–14.3 for groups and 8.0–21.1 for individuals. Thus, estimates of which changes are clinically relevant, are now available for future studies. We recommend using MIC values found by ROC analyses to evaluate changes in groups of patients, whereas MIC values identified by a dual criterion, including the reliability of changes, should be used for individual patients, for example, to identify individual responders in clinical studies or practice.
AbstractList ThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained. The purpose of this study was to determine values for minimal important change (MIC) for ThyPRO. A total of 435 patients treated for benign thyroid diseases completed ThyPRO at baseline and 6 weeks following treatment initiation. At 6 weeks follow-up, patients also completed Global Rating of Change items. For each 0-100 scale, two MIC values were identified: An MIC for groups, using the receiver operating characteristic (ROC) curve method and an MIC for individual patients, using the Reliable Change Index. ROC analyses provided group-MIC estimates of 6.3-14.3 (score range 0-100). Evaluation of area under the curve (AUC) supported the robustness for 9 of 14 scales (AUC > 0.7). Reliable Change Index estimates of individual-MIC were 8.0-21.1. For all scales but two, the individual-MIC values were larger than the group-MIC values. Interpretability of ThyPRO was improved by the establishment of MIC values, which was 6.3-14.3 for groups and 8.0-21.1 for individuals. Thus, estimates of which changes are clinically relevant, are now available for future studies. We recommend using MIC values found by ROC analyses to evaluate changes in groups of patients, whereas MIC values identified by a dual criterion, including the reliability of changes, should be used for individual patients, for example, to identify individual responders in clinical studies or practice.
Objective ThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained. The purpose of this study was to determine values for minimal important change (MIC) for ThyPRO. Methods A total of 435 patients treated for benign thyroid diseases completed ThyPRO at baseline and 6 weeks following treatment initiation. At 6 weeks follow-up, patients also completed Global Rating of Change items. For each 0–100 scale, two MIC values were identified: An MIC for groups, using the receiver operating characteristic (ROC) curve method and an MIC for individual patients, using the Reliable Change Index. Results ROC analyses provided group-MIC estimates of 6.3–14.3 (score range 0–100). Evaluation of area under the curve (AUC) supported the robustness for 9 of 14 scales (AUC > 0.7). Reliable Change Index estimates of individual-MIC were 8.0–21.1. For all scales but two, the individual-MIC values were larger than the group-MIC values. Conclusions Interpretability of ThyPRO was improved by the establishment of MIC values, which was 6.3–14.3 for groups and 8.0–21.1 for individuals. Thus, estimates of which changes are clinically relevant, are now available for future studies. We recommend using MIC values found by ROC analyses to evaluate changes in groups of patients, whereas MIC values identified by a dual criterion, including the reliability of changes, should be used for individual patients, for example, to identify individual responders in clinical studies or practice.
Objective: ThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained. The purpose of this study was to determine values for minimal important change (MIC) for ThyPRO. Methods: A total of 435 patients treated for benign thyroid diseases completed ThyPRO at baseline and 6 weeks following treatment initiation. At 6 weeks follow-up, patients also completed Global Rating of Change items. For each 0–100 scale, two MIC values were identified: An MIC for groups, using the receiver operating char acteristic (ROC) curve method and an MIC for individual patients, using the Reliable Change Index. Results: ROC analyses provided group-MIC estimates of 6.3–14.3 (score range 0–100). Evaluation of area under the curve (AUC) supported the robustness for 9 of 14 scales (AUC > 0.7). Reliable Change Index estimates of individual-MIC were 8.0–21.1. For all scales but two, the individual-MIC values were larger than the group-MIC values. Conclusions: Interpretability of ThyPRO was improved by the establishment of MIC values, which was 6.3–14.3 for groups and 8.0–21.1 for individuals. Thus, estimates of which changes are clinically relevant, are now available for future studies. We recommend using MIC values found by ROC analyses to evaluate changes in groups of patients, whereas MIC values identified by a dual criterion, including the reliability of changes, should be used for individual patients, for example, to identify individual responders in clinical studies or practice.
OBJECTIVEThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained. The purpose of this study was to determine values for minimal important change (MIC) for ThyPRO. METHODSA total of 435 patients treated for benign thyroid diseases completed ThyPRO at baseline and 6 weeks following treatment initiation. At 6 weeks follow-up, patients also completed Global Rating of Change items. For each 0-100 scale, two MIC values were identified: An MIC for groups, using the receiver operating characteristic (ROC) curve method and an MIC for individual patients, using the Reliable Change Index. RESULTSROC analyses provided group-MIC estimates of 6.3-14.3 (score range 0-100). Evaluation of area under the curve (AUC) supported the robustness for 9 of 14 scales (AUC > 0.7). Reliable Change Index estimates of individual-MIC were 8.0-21.1. For all scales but two, the individual-MIC values were larger than the group-MIC values. CONCLUSIONSInterpretability of ThyPRO was improved by the establishment of MIC values, which was 6.3-14.3 for groups and 8.0-21.1 for individuals. Thus, estimates of which changes are clinically relevant, are now available for future studies. We recommend using MIC values found by ROC analyses to evaluate changes in groups of patients, whereas MIC values identified by a dual criterion, including the reliability of changes, should be used for individual patients, for example, to identify individual responders in clinical studies or practice.
Objective ThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained. The purpose of this study was to determine values for minimal important change (MIC) for ThyPRO. Methods A total of 435 patients treated for benign thyroid diseases completed ThyPRO at baseline and 6 weeks following treatment initiation. At 6 weeks follow-up, patients also completed Global Rating of Change items. For each 0–100 scale, two MIC values were identified: An MIC for groups, using the receiver operating characteristic (ROC) curve method and an MIC for individual patients, using the Reliable Change Index. Results ROC analyses provided group-MIC estimates of 6.3–14.3 (score range 0–100). Evaluation of area under the curve (AUC) supported the robustness for 9 of 14 scales (AUC > 0.7). Reliable Change Index estimates of individual-MIC were 8.0–21.1. For all scales but two, the individual-MIC values were larger than the group-MIC values. Conclusions Interpretability of ThyPRO was improved by the establishment of MIC values, which was 6.3–14.3 for groups and 8.0–21.1 for individuals. Thus, estimates of which changes are clinically relevant, are now available for future studies. We recommend using MIC values found by ROC analyses to evaluate changes in groups of patients, whereas MIC values identified by a dual criterion, including the reliability of changes, should be used for individual patients, for example, to identify individual responders in clinical studies or practice.
Author Nordqvist, Selma Flora
Cramon, Per Karkov
Bjorner, Jakob Bue
Groenvold, Mogens
Boesen, Victor Brun
Feldt-Rasmussen, Ulla
Hegedüs, Laszlo
Watt, Torquil
Rasmussen, Åse Krogh
Bonnema, Steen Joop
AuthorAffiliation Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark
Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen, Denmark
Department of Internal Medicine, Herlev Gentofte Hospital, Copenhagen, Denmark
Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Department of Clinical Physiology and Nuclear Medicine, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark
Department of Public Health, University of Copenhagen, Copenhagen, Denmark
National Research Centre for the Working Environment, Copenhagen, Denmark
QualityMetric Incorporated, LLC, Johnston, Rhode Island, USA
AuthorAffiliation_xml – name: Department of Internal Medicine, Herlev Gentofte Hospital, Copenhagen, Denmark
– name: Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
– name: Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
– name: Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen, Denmark
– name: National Research Centre for the Working Environment, Copenhagen, Denmark
– name: Department of Public Health, University of Copenhagen, Copenhagen, Denmark
– name: QualityMetric Incorporated, LLC, Johnston, Rhode Island, USA
– name: Department of Clinical Physiology and Nuclear Medicine, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark
– name: Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark
Author_xml – sequence: 1
  givenname: Selma Flora
  surname: Nordqvist
  fullname: Nordqvist, Selma Flora
  organization: Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
– sequence: 2
  givenname: Victor Brun
  surname: Boesen
  fullname: Boesen, Victor Brun
  organization: Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
– sequence: 3
  givenname: Åse Krogh
  surname: Rasmussen
  fullname: Rasmussen, Åse Krogh
  organization: Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
– sequence: 4
  givenname: Ulla
  surname: Feldt-Rasmussen
  fullname: Feldt-Rasmussen, Ulla
  organization: Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
– sequence: 5
  givenname: Laszlo
  surname: Hegedüs
  fullname: Hegedüs, Laszlo
  organization: Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark
– sequence: 6
  givenname: Steen Joop
  surname: Bonnema
  fullname: Bonnema, Steen Joop
  organization: Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark
– sequence: 7
  givenname: Per Karkov
  surname: Cramon
  fullname: Cramon, Per Karkov
  organization: Department of Clinical Physiology and Nuclear Medicine, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark
– sequence: 8
  givenname: Torquil
  surname: Watt
  fullname: Watt, Torquil
  email: Torquil.Watt@regionh.dk
  organization: Department of Internal Medicine, Herlev Gentofte Hospital, Copenhagen, Denmark
– sequence: 9
  givenname: Mogens
  surname: Groenvold
  fullname: Groenvold, Mogens
  organization: Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen, Denmark
– sequence: 10
  givenname: Jakob Bue
  surname: Bjorner
  fullname: Bjorner, Jakob Bue
  organization: QualityMetric Incorporated, LLC, Johnston, Rhode Island, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33617467$$D View this record in MEDLINE/PubMed
BookMark eNp9kd9rFDEQgINUbK198Q-QfRRhdfJzd18EOU8tFCpSn0OSndyl7CVnNle4_95cr5b2xUCYZPLxZZJ5TU5iikjIWwofqeTwabloGW0BmHpBzhiIoeWKipMn61NyMc-3UEdPVc_hFTnlNd8J1Z0R8xUL5k2IIa6aQ9iYqQmbbcrFxNK4tYkrbHzKTVljnfucwthmnEzBsfmzM1Mo-yb5Zgoe6x7nElKMJmRsbtb7n7-u35CX3kwzXjzEc_L72_Jm8aO9uv5-ufhy1VrJVGklp6PwaBSXrrMd-B6YZXzkyhvDFB_Ayp45Lz0FNw4WgPbegYR-5Naj4Ofk8ugdk7nV21xfkvc6maDvEymvtMkluAm1E0rh4LpeOhRm9IOVEkBQwSi3XA3V9fno2u7sBkeHsWQzPZM-P4lhrVfpTvcgmex4Fbx_EOR0_yl6E2aH02Qipt2smRiYUpQPsqIfjqjLaZ4z-sdrKOhDi_VyoRnVhxZX-N3Twh7Rfw2tABwBG9LsQi0v-ODM_5x_AVR9s8M
CitedBy_id crossref_primary_10_3389_fendo_2023_1282608
crossref_primary_10_3389_fimmu_2022_1015491
crossref_primary_10_1089_lap_2022_0183
crossref_primary_10_1186_s13044_023_00178_0
crossref_primary_10_1111_cen_14649
crossref_primary_10_3389_fendo_2023_1283374
crossref_primary_10_1530_EC_22_0014
crossref_primary_10_3389_fendo_2022_1000682
crossref_primary_10_1111_ijcp_14967
crossref_primary_10_1089_thy_2022_0139
crossref_primary_10_1089_thy_2023_0263
crossref_primary_10_1089_thy_2021_0665
crossref_primary_10_3389_fendo_2022_1026262
crossref_primary_10_1038_s41574_021_00625_8
crossref_primary_10_1089_thy_2021_0454
ContentType Journal Article
Copyright 2021 The authors
2021 The authors 2021 The authors
Copyright_xml – notice: 2021 The authors
– notice: 2021 The authors 2021 The authors
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1530/EC-21-0026
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed
CrossRef

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
DocumentTitleAlternate Minimal important change for ThyPRO
S F Nordqvist et al
EISSN 2049-3614
EndPage 324
ExternalDocumentID oai_doaj_org_article_c466e9c785ce4adf9b5500414213b369
10_1530_EC_21_0026
33617467
Genre Journal Article
GroupedDBID 53G
5VS
AAFZV
ABLYK
ABSGY
ABSQV
ADACO
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
DIK
EBS
EE-
EJD
FRJ
GROUPED_DOAJ
GX1
H13
HYE
INIJC
IPNFZ
KQ8
M48
M~E
OK1
RHF
RIG
RPM
TBS
AIPOO
AOIJS
BTFSW
F9R
NPM
AAYXX
CITATION
PGMZT
7X8
5PM
ID FETCH-LOGICAL-b526t-531d4fea635c7b70f802b23d36faa26390b582cf5f10cd9b0018fc0508d3bfe43
IEDL.DBID RPM
ISSN 2049-3614
IngestDate Thu Jul 04 21:10:08 EDT 2024
Tue Sep 17 21:19:26 EDT 2024
Fri Aug 16 07:34:35 EDT 2024
Fri Aug 23 01:41:46 EDT 2024
Thu May 23 23:35:59 EDT 2024
Fri May 14 14:38:15 EDT 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords ThyPRO
patient-reported outcomes
interpretability
thyroid-related quality of life
minimal important change
Language English
License This work is licensed under a Creative Commons Attribution 4.0 International License.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b526t-531d4fea635c7b70f802b23d36faa26390b582cf5f10cd9b0018fc0508d3bfe43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052573/
PMID 33617467
PQID 2492661395
PQPubID 23479
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_c466e9c785ce4adf9b5500414213b369
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8052573
proquest_miscellaneous_2492661395
crossref_primary_10_1530_EC_21_0026
pubmed_primary_33617467
bioscientifica_primary_10_1530_EC_21_0026
PublicationCentury 2000
PublicationDate 2021-03-01
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bristol
PublicationTitle Endocrine Connections
PublicationTitleAlternate Endocr Connect
PublicationYear 2021
Publisher Bioscientifica Ltd
Bioscientifica
Publisher_xml – name: Bioscientifica Ltd
– name: Bioscientifica
SSID ssj0000816830
Score 2.3007588
Snippet Objective ThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained....
ThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained. The purpose...
Objective ThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained....
OBJECTIVEThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained. The...
Objective: ThyPRO is the standard thyroid patient-reported outcome (PRO). The change in scores that patients perceive as important remains to be ascertained....
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
bioscientifica
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 316
SubjectTerms interpretability
minimal important change
patient-reported outcomes
thypro
thyroid-related quality of life
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhpxxSmiZt3bRFJSXQg4itp_eYbDeEQpNSEshN6EkMXW9INof99x1JTliX0F56MAZbxrJmpPnGmvkGoc-UKW88DYQargj4G5y0TVREWGe5CqaVebvg-7k8u-LfrsX1WqmvFBNW6IHLwB05LmWYONUKF7jxcWIBU9e84bRhlsmSuteINWcqr8GpnEQuNEIBAhMGRmjgJhWsPppNCQUnOjMqbNuusEbm0Jyxecos_s9Bzz8jKNdM0ulL9GLAkvi4fMMO2gj9K7R73IMfPV_hQ5yjO_Nv811kvg5xL2CqcDrN4cluntF3v8Ql_xcDgsWACOFY3S06T3KmS_C4pF6u8CLiX10MOPcTJNobWDHx5c3qx8-LPXR1OrucnpGhvAKxgsolgdnneQwGIIdTVtWxramlzDMZjaGAXGorWuqiiE3tfOJObNroakB0ntkYOHuNNvtFH94izCJ42dbT1jvFvbOTAGuoiFFKw41pXIW-jIdZ3xYuDZ18EBCJnk01bXQSSYUOHiXw11YnSThPLRJLdr4AuqMH3dH_0p0KfXoUrYZZlbZKTB8WD_c68ygC0pmICr0pon56FQNtSkVaKqRGSjDqy_hO391k5u42Vw1k7_5H5_fRFk3xNTke7j3aXN49hA8AkJb2Y54LvwF3bw2x
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9UwFD_MCbKHiTo_6hcRRfAh2iZp0z6IzOsdQ5iK7MLeSj5dYbedd3dg_3tP0t5hZfpQCk3Shpxzkt9pTn4H4BXj0irLHGVKSIr-hqBl5iXNtdFCOlUWcbvg6EtxuBCfT_KTLdjk7xwH8OJa1y7kk1qszt7--tl_QIN_H7P38PTdfEYZ-sToTdyAm0xwETT9aIT5cUYOySVi2hGGgJhyXJJGptJp8x24xbFQxqzzu7oZ6CRjzM503Yr0_tdh0r9DK_9Yqw7uwO0RZJL9QSvuwpZr78HefosO9rInr0kM-4z_0_dAfRoDYnANI-G2xJbNMo5IuybDwWCC0JYgVMSrX3WNpfEIjLNkOJPZk86Ts8Y7EvuJom4VTqXk-LT_9v3rfVgczI9nh3TMu0B1zoo1RbO0wjuFWMRILVNfpkwzbnnhlWIIaVKdl8z43GepsYFUMSu9SRHqWa69E_wBbLdd6x4B4R7db21ZaY0U1ujK4eSae18USiiVmQTeTIe5Ph9INurgnKB06vmsZlkdpJPAy40E_lvrYxDOVY1Anx0fdKsf9WiNtRFF4Sojy9w4oayvNDpqqcgEy7jmRZXAi41oazS3sIeiWtddXtSRYBEhUJUn8HAQ9dWnNrqTgJwowaQv05K2OY2U3mVMJ8gf__OdT2CHhWiaGP32FLbXq0v3DOHQWj-Puv4bvbIHFA
  priority: 102
  providerName: Scholars Portal
Title Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO
URI http://dx.doi.org/10.1530/EC-21-0026
https://www.ncbi.nlm.nih.gov/pubmed/33617467
https://search.proquest.com/docview/2492661395
https://pubmed.ncbi.nlm.nih.gov/PMC8052573
https://doaj.org/article/c466e9c785ce4adf9b5500414213b369
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaHlAPIKA8wqMyAiFxSDfxI06OZdlSIS1UqJX2FvnZRmqSatke9t8zmSRVgxAHDnGkxFaszNj-xv5mhpAPjCunHfMx00LFYG-IOE-DiqWxRiiv8wyPC5bfs9ML8W0lVztEjr4wSNq3pjpqruujprpCbuVNbWcjT2x2tpznmHyNz3bJruL8nomO02-XSYInQyhSyZPZYh4zsJnB2tgnDziHNRvTyj80VR8vEkk504UJ4_f_DXT-yZ28txidPCaPBhRJj_vePiE7vnlKDo4bsKDrLf1IkdeJG-YHRH8ZGC-wSNHuVkPLqkbc3Wxo7_lLAbtSwIJwbddt5WL0cfGO9k6XW9oGel0FT7GfIMtGw1xJz6-2Zz9_PCMXJ4vz-Wk8JFaIjWTZJoZx50TwGsCGVUYlIU-YYdzxLGjNALMkRubMBhnSxLouamKaB5sAlnPcBC_4c7LXtI1_SSgPYF8bx3JnlXDWFB5mTxlClmmhdWoj8mn6m8ubPopG2VkfIJ1yMS9ZWnbSicj7UQL_rPW5E85djS4-Nj5o15floCWlFVnmC6tyab3QLhQGLLFEpIKl3PCsiMi7UbQljKfukEQ3vr39VWIERcA4hYzIi17Ud58adSciaqIEk75M34AKY8zuQWVf_XfL12SfdXQapL-9IXub9a1_C3hoYw5xHwHKr6sUyqXID3FE_AY9-g-u
link.rule.ids 230,315,733,786,790,870,891,2115,2236,24346,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIkEPPMsjPI1ASByym9jO61iWrRbolgptUW-RnzSiSaole1h-PRMnqboVQoJDFCl2lDgztr-Jv_kM8IayRAtNjU8FT3yMN7ifhjbxI6kkT4xIY7dcMD-MZ8f800l0sgXRkAvjSPtKFqPqrBxVxanjVp6XajzwxMZH80nqNl9j42twHfsrTS4F6W4AbveSYEEvRhqxYDyd-BSjZow3duAGYzhru43lb8miU4x0tJzNqckp-P8Jdl5lT16ajvbvwLehIR0L5cdo1ciR-nVF4_GfW3oXbvcAlex1xfdgy1T3YXevwuC8XJO3xFFG3b_4XRAfejINzn-kPZV4Z1E6SF81pEsqJgiLCcJMPNbLutC-S58xmnT5nGtSW3JWWEPcB0A3qQQOw2Rxuj76-uUBHO9PF5OZ3-_Z4MuIxo2PXVpzawTiGJXIJLBpQCVlmsVWCIpwKJBRSpWNbBgo3QoyhqlVAcJEzaQ1nD2E7aquzGMgzGLoLjVNtUq4VjIzODBH1sax4EKEyoN3m_bLzzuBjrwNbNDs-XSS0zBvze7B68G0f631vrX6RY1WettdqJff894sueJxbDKVpJEyXGibSQzyAh5yGjLJ4syDV4PP5NhV2_UXUZl69TN34owIn7LIg0edD108anBKD5IN79p4l80S9BknB977yJP_vvMl3Jwt5gf5wcfDz09hh7asHceyewbbzXJlniPsauQL18l-AzS7LuQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Ja9wwFBZtCiGHrmkbd1VpKfTgsS3J2zGdzJAuSYeSQMhFaG1MYnuYeg7TX99n2Q4zofSQgzHYErb8nqTvWZ--h9AHQlMtNDE-ESz1Id5gfhbZ1I-lkiw1IkvccsHRcXJ4yr6exWdrqb4caV_JYlRdlaOquHDcynmpgoEnFsyOxplLvkaDubbBXXQP-izJ1wJ1Nwi3-SRo2AuSxjQMJmOfQOQMMccO2qYUZm6XXP6-LDrVSEfN2ZyenIr_v6DnTQbl2pQ0fYjOh8Z0TJTL0bKRI_Xnhs7jrVr7CD3ogSre74o8RndM9QTt7lcQpJcr_BE76qj7J7-LxEFPqoF5ELenEmoWpYP2VYO7zcUY4DEGuAnHalEX2nfbaIzG3b7OFa4tviqswe4jgLtUAoZjfHKxmv388RSdTicn40O_z93gy5gkjQ9dWzNrBOAZlco0tFlIJKGaJlYIArAolHFGlI1tFCrdCjNGmVUhwEVNpTWMPkNbVV2ZPYSphRBeapJplTKtZG5ggI6tTRLBhIiUhz5t2pDPO6EO3gY4YHo-GXMS8db0Hno_mPe_pT63lr8u0Upwuwv14hfvTcMVSxKTqzSLlWFC21xCsBeyiJGISprkHno3-A2HLtuuw4jK1Mvf3Ik0AozKYw897_zo-lGDY3oo3fCwjXfZvAN-42TBez95ceuab9H27GDKv385_vYS7ZCWvOPIdq_QVrNYmteAvhr5xvWzv5RwMWQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determining+minimal+important+change+for+the+thyroid-related+quality+of+life+questionnaire+ThyPRO&rft.jtitle=Endocrine+Connections&rft.au=Nordqvist%2C+Selma+Flora&rft.au=Boesen%2C+Victor+Brun&rft.au=Rasmussen%2C+%C3%85se+Krogh&rft.au=Feldt-Rasmussen%2C+Ulla&rft.date=2021-03-01&rft.issn=2049-3614&rft.eissn=2049-3614&rft.volume=10&rft.issue=3&rft.spage=316&rft_id=info:doi/10.1530%2FEC-21-0026&rft_id=info%3Apmid%2F33617467&rft.externalDocID=33617467
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2049-3614&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2049-3614&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2049-3614&client=summon